Hassannia et al (2018) reported withaferin A as a natural ferroptosis-inducing agent in neuroblastoma, whose mechanism includes the canonical ferroptosis induction pathway (inactivation of glutathione peroxidase 4 [GPX4]) as well as the non-canonical pathway involving NRF2 signaling. The gene discussed is GPX4; the disease is neuroblastoma.